For breast cancer, low SMARCA1 expression was linked to poor OS (P = 0.04), relapse-free survival (RFS) (P = 0.011) and distant metastasis-free survival (DMFS) (P = 0.019) but not progress-free survival (PFS) (Fig 6A). Here, SMARCA1 is linked to breast carcinoma.